Cargando…

CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease

BACKGROUND: The mechanisms underlying the pathogenesis and progression of Parkinson’s disease (PD) remain elusive, but recent opinions and perspectives have focused on whether the inflammation process induced by microglia contributes to α-synuclein-mediated toxicity. Migration of microglia to the su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuanyuan, Niu, Mengyue, Zhao, Aonan, Kang, Wenyan, Chen, Zhichun, Luo, Ningdi, Zhou, Liche, Zhu, Xiongwei, Lu, Liming, Liu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909602/ https://www.ncbi.nlm.nih.gov/pubmed/31831012 http://dx.doi.org/10.1186/s12974-019-1646-6

Ejemplares similares

SNPs in SNCA, MCCC1, DLG2, GBF1 and MBNL2 are associated with Parkinson's disease in southern Chinese population
por: Zhao, Aonan, et al.
Publicado: (2020)

Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
por: Luo, Ningdi, et al.
Publicado: (2019)

Parkinson's disease peripheral immune biomarker profile: a multicentre, cross-sectional and longitudinal study
por: Li, Yuanyuan, et al.
Publicado: (2022)

Efficacy of idebenone in the Treatment of iRBD into Synucleinopathies (EITRS): rationale, design, and methodology of a randomized, double-blind, multi-center clinical study
por: Li, Yuanyuan, et al.
Publicado: (2022)

Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA
por: Li, Yuanyuan, et al.
Publicado: (2017)

Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease
por: Kim, Changyoun, et al.
Publicado: (2015)

MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
por: Geng, Lu, et al.
Publicado: (2023)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

Neuroprotective Effects of Intermittent Theta Burst Stimulation in Parkinson’s Disease (NET-PD): A Study Protocol for a Delayed-Start Randomized Double-Blind Sham-Controlled Trial
por: Li, Puyu, et al.
Publicado: (2022)

Evolution patterns of probable REM sleep behavior disorder predicts Parkinson’s disease progression
por: Ye, Guanyu, et al.
Publicado: (2022)

α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity
por: Hu, Zhaoyang, et al.
Publicado: (2016)

Age and sex differentially shape brain networks in Parkinson's disease
por: Chen, Zhichun, et al.
Publicado: (2023)

Contactless evaluation of rigidity in Parkinson's disease by machine vision and machine learning
por: Zhu, Xue, et al.
Publicado: (2023)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
por: Zella, Maria Angela Samis, et al.
Publicado: (2019)

Alpha-synuclein–mediated DNA damage, STING activation, and neuroinflammation in Parkinson’s disease
por: Standaert, David G., et al.
Publicado: (2022)

Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation
por: Vieira, Bruno Di Marco, et al.
Publicado: (2015)

Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells
por: Sarkar, Souvarish, et al.
Publicado: (2020)

Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson’s disease
por: Kuan, Wei-Li, et al.
Publicado: (2019)

Identification and Classification of Parkinsonian and Essential Tremors for Diagnosis Using Machine Learning Algorithms
por: Xing, Xupo, et al.
Publicado: (2022)

Unexpected Implication of SRP and AGO2 in Parkinson’s Disease: Involvement in Alpha-Synuclein Biogenesis
por: Hernandez, Sarah M., et al.
Publicado: (2021)

Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease
por: Gao, Hui-Ming, et al.
Publicado: (2011)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
por: Emamzadeh, Fatemeh Nouri
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease
por: Wang, Zerui, et al.
Publicado: (2020)

α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
por: Smith, Lynnae M., et al.
Publicado: (2012)

Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and α-synuclein oligomerization in a subacute MPTP mouse model of Parkinson’s disease
por: Leem, Yea-Hyun, et al.
Publicado: (2023)

Single-Molecule Detection of α-Synuclein Oligomers in Parkinson’s Disease Patients Using Nanopores
por: Liu, Yaxian, et al.
Publicado: (2023)

Copper(II) Binding to α-Synuclein, the Parkinson’s Protein
por: Lee, Jennifer C., et al.
Publicado: (2008)

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
por: Winslow, Ashley R., et al.
Publicado: (2010)

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy
por: Longhena, Francesca, et al.
Publicado: (2017)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
por: Mor, Danielle E, et al.
Publicado: (2018)

Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
por: Bridi, Jessika C., et al.
Publicado: (2018)

“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease
por: Ray, Bipul, et al.
Publicado: (2021)

Initiation and progression of α-synuclein pathology in Parkinson’s disease
por: Tofaris, George K.
Publicado: (2022)

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models
por: Iba, Michiyo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8c6h9nl2ckr61vc9f5ce8o0me4